AN INNOVATIVE REPURPOSING OF MEFLOQUINE; ASSESSMENT OF ITS THERAPEUTIC EFFICACY IN TREATING CRYPTOSPORIDIUM PARVUM INFECTION OF BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMIZED MICE

UPDATE IN DIAGNOSIS AND TREATMENT OF CRYPTOSPORIDIOSIS AN UPDATE REVIEW

PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS

AMELIORATING EFFECT OF NITAZOXANIDE LOADED CHITOSAN NANOPARTICLES ON INTESTINAL DYSPLASTIC CHANGES IN IMMUNOSUPPRESSED CRYPTOSPORIDIOSIS MURINE MODEL

THERAPEUTIC EFFICACY OF A CYSTEINE PROTEASES INHIBITOR (PHENYL VINYL SULFONE) EITHER ALONE OR COMBINED WITH NIGELLA SATIVA ON EXPERIMENTAL CRYPTOSPORIDIOSIS

DETECTION OF CRYPTOSPORIDIUM-INDUCED INTESTINAL TISSUE ALTERATIONS IN DEXAMETHASONE TREATED & UN-TREATED MICE

IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALIN

COMPARATIVE STUDY BETWEEN THE EFFECT OF NITAZOXANIDE AND PAROMOMYCINE IN TREATMENT OF CRYPTOSPORIDIOSIS IN HOSPITALIZED CHILDREN

Effect of piperazine citrate on experimentally cryptosporidium parvum infected mice

EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE